ArticleAnnals of hematology2026

Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement.

Marco Frigeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.